Investment
Features
FeesSafety
Academy
More
Pluang+

Syra Health expands wellness program to support Wake County public health workers' mental well-being.

Market News
01 Sep 2026
PRNewsWire
View Source
Bullish
pluang ai news

Syra Health has expanded its partnership with Wake County Public Health in North Carolina by launching Wellness S.P.A. 2.0, an employee wellness program aimed at supporting mental and emotional health, preventing burnout, and building resilience among public health workers. The program follows a successful pilot and includes three six-week cohorts focusing on stress management topics such as sleep hygiene, communication, and self-care. This expansion highlights the growing demand for evidence-based wellness solutions to help frontline public health employees manage increasing job demands. A second round of the program is planned for later in 2026, with a third round in early 2027.

More News

Bunzl PLC beats earnings estimates, raises margin forecast, and launches £500M share buyback.

Bunzl PLC beats earnings estimates, raises margin forecast, and launches £500M share buyback.

Bunzl PLC reported stronger-than-expected financial results with an EPS of $0.60, surpassing the $0.56 consensus. Revenue reached $8.04 billion, driven by a 3.2% underlying growth, especially in North America. The operating margin improved to 7.3%, p...

Company Fundamentals
Bullish
58 minutes ago
Palo Alto Networks expects strong Q3 earnings and revenue growth amid positive cybersecurity trends.

Palo Alto Networks expects strong Q3 earnings and revenue growth amid positive cybersecurity trends.

Palo Alto Networks is set to report strong earnings per share (EPS) of $0.98 and revenue of $3.35 billion for the upcoming quarter, reflecting significant growth from last year. Investor optimism is driven by robust cybersecurity sector trends and a ...

Company Fundamentals
Bullish
1 hour ago
Medtronic beats Q3 earnings and revenue estimates, boosts outlook with $700M investment in Heart Tech and Robotics.

Medtronic beats Q3 earnings and revenue estimates, boosts outlook with $700M investment in Heart Tech and Robotics.

Medtronic reported Q3 earnings per share of $1.45, surpassing estimates of $1.39, and revenue of $9.76 billion, above the $9.55 billion consensus. The strong financial results reflect broad demand for its cardiovascular devices. The company raised it...

Company Fundamentals
Bullish
1 hour ago
Dell Technologies set for record Q2 earnings driven by AI server demand and strong revenue growth.

Dell Technologies set for record Q2 earnings driven by AI server demand and strong revenue growth.

Dell Technologies is expected to report record second-quarter earnings with EPS around $4.91 and revenue near $44.89 billion, fueled by high demand for its AI-optimized servers. This would mark a significant increase from last year's $29.78 billion a...

Company Fundamentals
Bullish
2 hours ago
Protagonist Therapeutics' price target raised to $180 after FDA approves new drug MIMRYLO.

Protagonist Therapeutics' price target raised to $180 after FDA approves new drug MIMRYLO.

Protagonist Therapeutics saw its stock price target raised to $180 by Barclays following the FDA approval of MIMRYLO, a first-in-class drug for polycythemia vera. The approval was based on strong Phase 3 trial results with 76.9% patient response, tri...

Analyst Insights
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App